Exabeam, Inc.
USPTO PatentsView assignee record - 21 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (Transmission OF Digital Information, e.g. Telegraphic Communication).
The verdict
According to USPTO PatentsView, Exabeam ranks #13,979 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 5 technology areas.
- #13,979
- of 49,997 US assignees by volume
- 48th percentile
- by Innovation Score (34.6/100)
- 20.0
- avg claims per patent
- +117%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13979 · US Corporation #13,979 · 21 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 21 grants
- MID-PACK #13,979/49,997
- PHOTO-FINISH EpiVax
- CPC-NARROW H04L · 5 areas
- INNOV-THIN 34.6/100
- CLAIMS-DENSE 20.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +117% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: EpiVax Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Exabeam’s 34.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Exabeam
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Exabeam · this assignee
Exabeam · this assignee
35 score
- Short Circuit · near
Short Circuit · near
35 score
- Chyng Hong · near
Chyng Hong · near
35 score
- Medical Diagnostic… · near
Medical Diagnostic… · near
35 score
- Quixey · near
Quixey · near
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Exabeam's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Exabeam?
Each dot is one of Exabeam’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exabeam’s own 20.0 claims/patent is ABOVE the 18.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Exabeam's grants concentrate
Exabeam, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 95.2% of grants classified under H04L (Transmission OF Digital Information, e.g. Telegraphic Communication). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2018. By volume, Exabeam sits between EpiVax Inc. and Eyenovia, Inc..
Exabeam's three-year grant acceleration
Exabeam, Inc. shows 6 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Exabeam's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Epivax
EpiVax Inc.
21 patents
- Erber
Erber AG
21 patents
- Etagen
EtaGen, Inc.
21 patents
- Evonik Oxeno & KG
Evonik Oxeno GmbH & Co. KG
21 patents
- Excelitas Canada
Excelitas Canada, Inc.
21 patents
- Exegy Incorporated
Exegy Incorporated
21 patents
- Eyepoint Pharmace…
EyePoint Pharmaceuticals, Inc.
21 patents
- Eyenovia
Eyenovia, Inc.
21 patents
- Exabeam ◀
Exabeam, Inc.
21 patents
What this shows Exabeam holds 21 patents at rank #13,979, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Exabeam
By rank, the assignees closest to #13,979 in granted patent volume.
- EpiVax Inc. #13,975 · 21 patents
- Erber AG #13,976 · 21 patents
- EtaGen, Inc. #13,977 · 21 patents
- Evonik Oxeno GmbH & Co. KG #13,978 · 21 patents
- Excelitas Canada, Inc. #13,980 · 21 patents
- Exegy Incorporated #13,981 · 21 patents
- EyePoint Pharmaceuticals, Inc. #13,982 · 21 patents
- Eyenovia, Inc. #13,983 · 21 patents
Leaders in H04L (Transmission OF Digital Information)
Other assignees with the most granted patents in Exabeam's primary technology class.
- International Business Machines Corporation 15,969 in class
- Qualcomm Incorporated 13,594 in class
- Huawei Technologies Co., Ltd. 11,697 in class
- Samsung Electronics Co., Ltd. 10,543 in class
- LG Electronics Inc. 9,062 in class
- Telefonaktiebolaget LM Ericsson (Publ) 8,543 in class
- Cisco Technology, Inc. 7,502 in class
- Microsoft Technology Licensing, LLC 7,301 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Exabeam, neither rank-band nor same-CPC leaders (those blocks stay above). In H04L (Transmission OF Digital Information), Exabeam ranks #1,367 of 8,956 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (35 here).
Exabeam's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 48th percentile higher than 48% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 9.5% |
| 2018 | 1 | 4.8% |
| 2019 | 3 | 14.3% |
| 2020 | 3 | 14.3% |
| 2021 | 4 | 19.0% |
| 2022 | 2 | 9.5% |
| 2023 | 1 | 4.8% |
| 2024 | 3 | 14.3% |
| 2025partial year | 2 | 9.5% |
Which technologies does Exabeam, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Exabeam, Inc.'s patent record in context - here's where to go next.
- Exabeam, Inc.'s lead technology class is H04L (Transmission OF Digital Information, e.g. Telegraphic Communication), 95.2% of its portfolio - see every assignee active in that class. Explore H04L
- Ranked #13,979 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Exabeam, Inc. against EpiVax Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.